Disease activity in systemic lupus erythematosus is associated with an altered expression of low-affinity Fcγ receptors and costimulatory molecules on dendritic cells

Immunology

Volumn 128, Issue 3, 2009, Pages 334-341

  Carreño, Leandro J ^a   Pacheco, Rodrigo ^a   Gutierrez, Miguel A ^b   Jacobelli, Sergio ^b   Kalergis, Alexis M ^a,b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Dendritic cells; Fc receptors; Systemic lupus erythematosus

Indexed keywords

ANTIRHEUMATIC AGENT; AZACORTINE; AZATHIOPRINE; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FC RECEPTOR; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RITUXIMAB; UNCLASSIFIED DRUG;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNITY; BLOOD; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DENDRITIC CELL; DISEASE ACTIVITY; DONOR; FEMALE; HUMAN; HUMAN CELL; MALE; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIGENS, CD; CELL DIFFERENTIATION; DENDRITIC CELLS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOMODULATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RECEPTORS, IGG; SELF TOLERANCE; SEVERITY OF ILLNESS INDEX;

EID: 70349675867     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03138.x     Document Type: Article

References (35)

1. Gonzalez PA, Carreno LJ, Figueroa CA, Kalergis AM. Modulation of immunological synapse by membrane-bound and soluble ligands. Cytokine Growth Factor Rev 2007 18 : 19 31.
2. Iruretagoyena MI, Wiesendanger M, Kalergis AM. The dendritic cell-T cell synapse as a determinant of autoimmune pathogenesis. Curr Pharm Des 2006 12 : 131 147.
3. Kalergis AM. Modulation of T cell immunity by TCR/pMHC dwell time and activating/inhibitory receptor pairs on the antigen-presenting cell. Curr Pharm Des 2003 9 : 233 244.
4. Lipscomb MF, Masten BJ. Dendritic cells: immune regulators in health and disease. Physiol Rev 2002 82 : 97 130.
5. Janeway CA Jr. How the immune system works to protect the host from infection: a personal view. Proc Natl Acad Sci USA 2001 98 : 7461 7468.
6. Janeway CA Jr., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002 20 : 197 216.
7. Kleinau S. The impact of Fc receptors on the development of autoimmune diseases. Curr Pharm Des 2003 9 : 1861 1870.
8. Lorenz HM, Herrmann M, Kalden JR. The pathogenesis of autoimmune diseases. Scand J Clin Lab Invest Suppl 2001 235 : 16 26.
9. Nimmerjahn F, Ravetch JV. Fc-receptors as regulators of immunity. Adv Immunol 2007 96 : 179 204.
10. Wollina U. Immune complexes - pathogenetic factors of autoimmune systemic lupus erythematosus. Allerg Immunol (Leipz) 1984 30 : 3 13.
11. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol 2001 19 : 275 290.
12. Billadeau DD, Leibson PJ. ITAMs versus ITIMs: striking a balance during cell regulation. J Clin Invest 2002 109 : 161 168.
13. Brown EE, Edberg JC, Kimberly RP. Fc receptor genes and the systemic lupus erythematosus diathesis. Autoimmunity 2007 40 : 567 581.
14. Thien M, Renger D, Deicher H, Pichler WJ. Alteration of Fc-receptor phenotype and proliferative capacity of Fc-IgG-receptor positive lymphocytes through interaction with soluble immune complexes of patients with SLE or RA. Rheumatol Int 1985 5 : 127 132.
15. Clynes R, Maizes JS, Guinamard R, Ono M, Takai T, Ravetch JV. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J Exp Med 1999 189 : 179 185.
16. Isakov N. ITIMs and ITAMs. The Yin and Yang of antigen and Fc receptor-linked signaling machinery. Immunol Res 1997 16 : 85 100.
17. Pan L, Pei P. Signaling transduction by IgG receptors. Chin Med J (Engl) 2003 116 : 487 494.
18. Anolik JH. B cell biology and dysfunction in SLE. Bull NYU Hosp Jt Dis 2007 65 : 182 186.
19. Cohen PL. T- and B-cell abnormalities in systemic lupus. J Invest Dermatol 1993 100 : 69S 72S.
20. Driver CB, Ishimori M, Weisman MH. The B cell in systemic lupus erythaematosus: a rational target for more effective therapy. Ann Rheum Dis 2008 67 : 1374 1381.
21. Inman RD. Immune complexes in SLE. Clin Rheum Dis 1982 8 : 49 62.
22. Ivan E, Colovai AI. Human Fc receptors: critical targets in the treatment of autoimmune diseases and transplant rejections. Hum Immunol 2006 67 : 479 491.
23. Decker P, Kotter I, Klein R, Berner B, Rammensee HG. Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2006 45 : 1087 1095.
24. Ding D, Mehta H, McCune WJ, Kaplan MJ. Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J Immunol 2006 177 : 5878 5889.
25. Mendoza-Naranjo A, Saez PJ, Johansson CC et al. Functional gap junctions facilitate melanoma antigen transfer and cross-presentation between human dendritic cells. J Immunol 2007 178 : 6949 6957.
26. Foell J, Mittler RS. Costimulatory molecules as immunotherapeutic targets in systemic lupus erythematosus. Springer Semin Immunopathol 2006 28 : 153 162.
27. Inman BA, Frigola X, Dong H, Kwon ED. Costimulation, coinhibition and cancer. Curr Cancer Drug Targets 2007 7 : 15 30.
28. Zheng Y, Manzotti CN, Liu M, Burke F, Mead KI, Sansom DM. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J Immunol 2004 172 : 2778 2784.
29. Herrada AA, Contreras FJ, Tobar JA, Pacheco R, Kalergis AM. Immune complex-induced enhancement of bacterial antigen presentation requires Fcgamma receptor III expression on dendritic cells. Proc Natl Acad Sci USA 2007 104 : 13402 13407.
30. Kalergis AM, Ravetch JV. Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J Exp Med 2002 195 : 1653 1659.
31. Gladman DD, Urowitz MB, Goldsmith CH et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997 40 : 809 813.
32. Su K, Yang H, Li X, Gibson AW, Cafardi JM, Zhou T, Edberg JC, Kimberly RP. Expression profile of FcgammaRIIb on leukocytes and its dysregulation in systemic lupus erythematosus. J Immunol 2007 178 : 3272 3280.
33. Blank MC, Stefanescu RN, Masuda E et al. Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus. Hum Genet 2005 117 : 220 227.
34. Su K, Li X, Edberg JC, Wu J, Ferguson P, Kimberly RP. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. II. Differential binding of GATA4 and Yin-Yang1 transcription factors and correlated receptor expression and function. J Immunol 2004 172 : 7192 7199.
35. Su K, Wu J, Edberg JC, Li X, Ferguson P, Cooper GS, Langefeld CD, Kimberly RP. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus. J Immunol 2004 172 : 7186 7191.